FIB
REGN icon

First Interstate Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

First Interstate Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-201
Closed -$211K – 191
2024
Q3 		$211K Buy
201
+1
+0.5% +$1.11K 0.01% 176
2024
Q2 		$210K Buy
+200
New +$194K 0.01% 162
2022
Q4 		– Sell
-393
Closed -$270K – 191
2022
Q3 		$270K Buy
393
+18
+5% +$11.3K 0.02% 150
2022
Q2 		$222K Hold
375
– – 0.02% 155
2022
Q1 		$262K Hold
375
– – 0.02% 108
2021
Q4 		$237K Hold
375
– – 0.02% 103
2021
Q3 		$227K Hold
375
– – 0.02% 101
2021
Q2 		$209K Buy
+375
New +$190K 0.02% 109
2020
Q4 		– Sell
-395
Closed -$221K – 107
2020
Q3 		$221K Sell
395
-2,070
-84% -$1.26M 0.03% 96
2020
Q2 		$1.54M Buy
2,465
+870
+55% +$494K 0.21% 63
2020
Q1 		$779K Sell
1,595
-237
-13% -$97.8K 0.19% 70
2019
Q4 		$688K Sell
1,832
-157
-8% -$52.8K 0.15% 86
2019
Q3 		$552K Buy
1,989
+16
+0.8% +$4.74K 0.13% 96
2019
Q2 		$618K Sell
1,973
-91
-4% -$30.3K 0.14% 92
2019
Q1 		$848K Hold
2,064
– – 0.19% 74
2018
Q4 		$771K Hold
2,064
– – 0.19% 78
2018
Q3 		$834K Sell
2,064
-106
-5% -$40.3K 0.18% 83
2018
Q2 		$749K Sell
2,170
-13
-0.6% -$4.07K 0.17% 87
2018
Q1 		$752K Buy
2,183
+701
+47% +$244K 0.17% 87
2017
Q4 		$557K Buy
1,482
+126
+9% +$51K 0.12% 104
2017
Q3 		$606K Sell
1,356
-52
-4% -$24.7K 0.13% 98
2017
Q2 		$692K Sell
1,408
-74
-5% -$32.4K 0.14% 92
2017
Q1 		$574K Sell
1,482
-29
-2% -$10.7K 0.12% 103
2016
Q4 		$555K Buy
1,511
+415
+38% +$158K 0.11% 107
2016
Q3 		$441K Buy
+1,096
New +$440K 0.09% 127
2015
Q4 		– Sell
-610
Closed -$284K – 810
2015
Q3 		$284K Buy
+610
New +$328K 0.06% 169

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

First Interstate Bank's REGN Position: Q4 2024 in Review

First Interstate Bank sold out of Regeneron Pharmaceuticals (REGN) in Q4 2024, closing a stake of 201 shares — an estimated $211K sold.

First Interstate Bank first reported a position in REGN in Q3 2015 and held it in 26 quarters. The position peaked at $1.54M in Q2 2020. 1,320 funds tracked by Wall St. Rank hold REGN as of Q4 2024.

  • First Interstate Bank reported no remaining Regeneron Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • First Interstate Bank sold 201 Regeneron Pharmaceuticals shares in Q4 2024, an estimated $211K.
  • First Interstate Bank first reported a position in Regeneron Pharmaceuticals in Q3 2015 and held it in 26 quarters.
  • First Interstate Bank's Regeneron Pharmaceuticals position peaked at $1.54M in Q2 2020.
  • 1,320 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2024.

Based on First Interstate Bank's 13F filing for Q4 2024, filed 4 Feb 2025.